Mission Bay Capital — Full Portfolio

Caribou Biosciences is a clinical-stage biopharmaceutical company developing CRISPR genome-editing therapies, including off-the-shelf CAR-T cell therapies for hematologic malignancies and armored cell therapies using its Cas12a chRDNA platform.

BiotechMedical DevicesBerkeley, US

Jennifer Doudna(Founder)RHRachel Haurwitz(Founder)inMartin Jinek(Founder)Andrew May(Executive Officer)James Berger(Founder)

BoardJRJenny Rooke(Director)in

Co-investorsALAliment CapitalAVAvego BioScience CapitalF-F-Prime CapitalIAIA Seed VenturesLILifeSci Venture PartnersMIMission Biocapital+3 more

Alessa Therapeutics develops a proprietary drug-delivery platform for sustained and localized release of therapies to treat early-stage prostate cancer.

BiotechHealthtechMedical DevicesSan Carlos, US

PMPamela Munster(Founder, Director & Chief Scientific Advisor)inCam Gallagher(President & Chief Executive Officer)inJMJohn Maroney(Executive Officer, Director)in

BoardZCZachary Collins(Executive Officer)inSTSteve Tregay(Director)inAMAnnie Mitsak(Director)in

Co-investorsCUCure VenturesMIMission Biocapital

Nobell Foods produces plant-based dairy cheese made from soybean plants engineered to grow casein protein, working with Midwest farmers.

BiotechClimate TechConsumerFoodTechSan Francisco, US

MRMagi Richani(CEO)inShu Li(Founder/CSO)

BoardChris Rivest(Director)VPVijay Pande(Director)inKyle Vogt(Director)

Co-investorsAGAgFunderANAndreessen HorowitzDCDCVC (Data Collective)MIMission BiocapitalUNUnovis Asset ManagementY Y Combinator+7 more

Avvio Medical develops Microbubble SonoLithotripsy, a minimally invasive outpatient procedure that uses low-intensity ultrasound to break down ureteral stones without requiring general anesthesia or stents.

Deep TechHealthtechMedical DevicesSan Francisco, US

Co-investorsBABaruch Future VenturesBEBerkeley CatalystCLCloudStone CapitalMIMission Biocapital

Asher Bio develops selective immunotherapy drugs that target specific immune cell types to promote beneficial effects while minimizing toxicity.

BiotechHealthtechMedical DevicesSan Francisco, US

IDIvana Djuretic(Founder)inAYAndy Yeung(Drug discovery)inYik Andy Yeung(Executive Officer, Director, Promoter)

Co-investorsEMEmles Venture PartnersGOGoAhead VenturesMIMission BiocapitalRARA CapitalWEWellington ManagementY Y Combinator+9 more

BiotechRedwood City, US

William Robinson(Director)LSLawrence Steinman(Director)TSTito Serafini(Executive Officer, Director)

BoardBrian Atwood(Director)Franklin Berger(Director)

Co-investorsAIAisling CapitalECEcoR1 CapitalEVEvolution VC PartnersMIMission Biocapital

Bolt Threads was a manufacturer of biomaterials for personal care formulations.

BiotechNew MaterialsFoxboro, US

Ethan Mirsky(Founder)David Breslauer(Founder)Daniel Widmaier(Executive Officer, Director)Dan Widmaier(Founder)

BoardJerry Fiddler(Director)SVSteven Vassallo(Director)in

Co-investorsKIKicker VenturesKYKyber Knight CapitalMIMission Biocapital8V8VCBABaillie GiffordCPCPT Capital+6 more

BiotechLafayette, US

PEPeter Emtage(Executive Officer)inGreg Giotta(Executive Officer)Brian Atwood(Executive Officer, Director, Promoter)

BoardFred Cohen(Executive Officer, Director, Promoter)BBBrook Byers(Director)inArie Belldegrun(Director)

Co-investorsKLKleiner PerkinsMIMission BiocapitalOUOUP (Osage University Partners)

HealthtechHayward, US

GDGUY DIPIERRO(Director)inALAN LEVY, PH.D.(Executive Officer, Director)ANTHONY RIMAC(Executive Officer)ALAN LEVY(Executive Officer, Director)

BoardELIZABETH ROCKETT(Director)WHWENDE HUTTON(Director)in

Co-investorsCOCota CapitalEMEmergent Medical Partners, LLPFOFountain Healthcare PartnersKAKaiser Permanente Ventures5A5AM VenturesCACanaan Partners+2 more

Circle Pharma develops cancer treatments using macrocycle therapies designed to reduce side effects compared to conventional therapies.

BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US

MPMatthew P. Jacobson(Co-founder)Scott R. Lokey(Director)DJDavid J. Earp(President & CEO)inPaul Park(Executive Officer)

BoardTSThilo Schroeder(Director)inWHWalter H. Moos(Director)

Co-investorsBEBerkeley CatalystHEHemisphere Ventures LLCJUJude GomilaLILifeforce CapitalMIMission BiocapitalNENextech Invest+4 more

Dren Bio is a clinical-stage biopharmaceutical company developing novel antibody therapeutics designed to selectively eliminate pathogenic cells and disease-causing agents, with a pipeline targeting oncology, autoimmune diseases, immunology, and neurology.

BiotechHealthtechMedical DevicesFoster City, US

NTNenad Tomasevic(Founder)

BoardIvan Trifunovich(Director)John Wesley(Founder)

Co-investors8V8VCAIAisling CapitalHBHBM Healthcare InvestmentsHBHBM PartnersJAJacket River Capital PartnersMIMission Biocapital+5 more

eFFECTOR Therapeutics was a clinical-stage biopharmaceutical company.

BiotechSolana Beach, US

Stephen F. Worland, Ph.D.(Executive Officer, Director)AMAlana McNulty(Executive Officer)in

BoardSimeon George(Director)JRJonathan Root(Director)inKen Haas(Director)Laurence Lasky(Director)

Co-investorsASAstellas Venture Management LLCMIMission BiocapitalOUOUP (Osage University Partners)PFPfizer Venture InvestmentsUSUS Venture PartnersSOSofinnova Ventures

Epiodyne develops small-molecule opioids designed to optimize therapeutic outcomes, with initial focus on safer pain relief and improved opioid use disorder treatment with reduced addiction and respiratory depression risk.

BiotechHealthtechMedical DevicesSan Francisco, US

Brian Shoichet(Founder)DCDouglas Crawford, Ph.D.(CEO)DGDon Gehlert, Ph.D.(Head of Biology)in

BoardDCDouglas Crawford(Executive Officer, Director)in

Co-investorsMEMenlo VenturesMIMission BiocapitalKLKleiner Perkins

Cell Microsystems develops laboratory instruments and platforms for cell engineering, culture, isolation, and analysis, including single-cell sorting, 3D cell culture, cell counting, tissue dissociation, and automated electrophysiology.

BiotechDeep TechHardware

Co-investorsCLClaremont Creek VenturesMIMission BiocapitalSISignet Healthcare PartnersWEWestern Technology Investment

Glycomine develops therapeutics for rare diseases, many of which currently lack disease-modifying treatment options.

BiotechSan Francisco, US

Agnes Rafalko(Executive Officer, Director)inSASteven Axon(Chief Executive Officer)inHAHicham Alaoui(Chief Scientific Officer)inRMRose Marino(Chief Medical Officer)inPMPeter McWilliams(Chief Business Officer)GHGeoffrey Hird(Chief Technology Officer)in

Co-investorsADAdvent Life SciencesASAsahi Kasei Corporate Venture CapitalCHChiesi VenturesCTCTI Life Sciences Fund L.P.MIMission BiocapitalRERemiges Ventures, Inc.+6 more

Rajatesh Gudibande(Founder)inMeet Vora(Founder)in

Co-investorsPLPlug and Play Ventures

Invenio develops rapid on-site tissue imaging systems combined with AI to improve cancer patient care.

AI & Machine LearningBiotechDeep TechMedical DevicesSanta Clara, US

JTJay Trautman(President & CEO, Co-Founder)inCFChris Freudiger(Chief Technology Officer, Co-Founder)inXXXiaoliang Xie(Director)

BoardDCDoug Crawford(Director)in

Co-investorsBEBerkeley CatalystMIMission Biocapital

Kit provides email marketing and commerce tools for creators and independent businesses to reach audiences and monetize their work through newsletters and storefronts.

Creator EconomyMarketing TechSaaS

NBNathan Barry(Founder)in

Co-investorsAUAUTHENTIC VENTURESBRBrighter CapitalEXExpaGAGaingelsMIMission BiocapitalWAWAGMI Ventures+4 more

Mammoth Bio develops technology to read and write the code of life, operating in the biotechnology sector.

BiotechDeep TechMedical DevicesBrisbane, US

JDJennifer Doudna(Founder)inTMTrevor Martin(Founder)inJCJanice Chen(Founder)inLHLucas Harrington(Founder)inATAshley Tehranchi(Founder)in

BoardUrshit Parikh(Director)

Co-investors8V8VCBEBerkeley FrontierCACalifornia Innovation FundDEDecheng CapitalFOForesite CapitalMAMayfield Fund+12 more

Targeting mitochondria for neurodegenerative disease therapies.

BiotechNew York, US

NHNicholas Hertz(Director)Doug Crawford(Director)Daniel de Roulet, Jr.(Executive Officer, Director)

BoardJohannes Fruehauf(Director)

Co-investorsMIMission BiocapitalPFPfizer Venture Investments

MPM Capital is a venture capital and life sciences investment firm that backs companies in biotech, therapeutics, and healthcare innovation, with a focus on translating scientific research into transformative medicines and treating severe diseases.

BiotechBoston, US

AGAnsbert Gadicke(Chairman)inCBChris Bardon(Managing Partner)inAGAnsbert Gadicke, M.D.(Managing Partner; founded MPM in 1992)inLELuke Evnin, Ph.D.(Advisor; co-founder of predecessor company MPM Capital)inChristiana Bardon, M.D., M.B.A.(Managing Partner)

Berkeley, US

Co-investorsAUAutodesk FoundationAVAVA AngelsBEBerkeley SkyDeck FundCRCRV (Charles River Ventures)MEMelbourne Accelerator Program (MAP)MOMoonhill Capital+1 more

Nitrase Therapeutics is a clinical-stage biopharmaceutical company using its NITROME platform to develop therapeutics based on nitrases, a class of enzymes it discovered that drive protein nitration.

BiotechHealthtechLongevity

Irene Griswold-Prenner(Founder & Chief Executive Officer)in

Co-investorsDEDementia Discovery FundMIMission BiocapitalSOSofinnova PartnersSVSV Health InvestorsABAbbVie

HealthtechSan Francisco, US

Matthew F. Krummel, Ph.D.(Director)SPSteven P. James(Executive Officer, Director, Promoter)inLeon Chen, Ph.D.(Director)CGCarol Gallagher(Director)inJoshua Resnick, M.D.(Director)

BoardMichael Powell(Director)

Co-investorsMIMission BiocapitalNENew Enterprise Associates (NEA)OUOUP (Osage University Partners)SOSofinnova VenturesOROrbiMedSOSofinnova Venture Partners

BiotechSouth San Francisco, US

MBMARTIN BABLER(Executive Officer, Director)in

BoardPTPETER THOMPSON(Director)inSASRINIVAS AKKARAJU(Director)MDMICHAEL DYBBS(Director)inSIMEON GEORGE(Director)LEWIS J. SHUSTER(Director)

Co-investorsACAccess BiotechnologyMIMission BiocapitalSOSofinnova VenturesSRSR One Capital ManagementNENew Leaf Venture PartnersOROrbiMed+1 more

QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.

BiotechDeep TechMedical DevicesCambridge, US

KEKevin Eggan(Founder, QurAlis; Group Vice President, Head of Research and Early Development, BioMarin Pharmaceutical)inRoet(Co-founder)Woolf(Co-founder)KRKasper Roet(Founder, Chief Executive Officer)inSVShafique Virani(Executive Officer)inJBJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in

Co-investorsALALS Investment FundDODolby Family VenturesDRDroia VenturesINInkefMCMC Healthcare VenturesMIMission Biocapital+8 more

Symbiome develops skin microbiome-based wellness products that restore ancestral skin health through proprietary fermentation and Amazonian botanical ingredients.

ConsumerHealthtechWellness & FitnessSan Francisco, US

LWLarry Weiss(Executive Officer, Director)Adam Klausner(Executive Officer)Vicki Levine(Executive Officer, Director)

BoardADAdam D'Augelli(Director)in

Co-investorsBOBold Capital PartnersMIMission BiocapitalGIGISEV Family OfficeTRTrue Ventures

Vedere Bio develops optogenetics-based gene therapies for inherited retinal diseases (IRDs) and geographic atrophy (GA), using proprietary AAV vectors for intravitreal administration to restore vision in visually impaired patients globally.

BiotechDeep TechMedical DevicesCambridge, US

Co-investorsMIMission Biocapital

Wildtype grows salmon directly from fish cells using cellular agriculture, allowing production of seafood without wild-caught or farmed fish.

BiotechClimate TechFoodTechSan Francisco, US

JKJustin Kolbeck(Founder)inAEArye Elfenbein(Founder)inJustin Kolbeck Arye Elfenbein(Founder)

BoardJohn Melas-Kyriazi(Director)

Co-investorsBABay Bridge Ventures ClimateCRCRV (Charles River Ventures)MAMaven VenturesMIMission BiocapitalRORoot Ventures Manager, LlcS2S2G Investments+19 more